Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 280 of 6351
-
New drug aims to shrink rare adrenal tumors
Disease control Not yet recruitingThis study is to examine the effects of oral daily zanzalintinib in participants with unresectable, progressive metastatic pheochromocytoma or paraganglioma.
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a Drug-Radiation combo outsmart Treatment-Resistant colorectal cancer?
Disease control Not yet recruitingTo learn if the experimental drug S-531011 plus RadScopalTM radiation therapy can help to control previously treated metastatic colorectal cancer.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Quarter-Sized implant could free type 1 diabetes patients from daily insulin
Disease control Not yet recruitingThis study will evaluate the safety and performance of ENCRT-103-hPI, which is a cargo of primary islets inside Encellin's ENC-103-CED. The 103 offers a soft pillow-like encasing to contain and protect the cells from the immune system. The product is implanted in the upper arm or…
Phase 1 • Sponsor: Encellin • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New drug could shorten hospital stays for rare drug reaction
Disease control Not yet recruitingDrug Reaction with eosinophilia and Systemic Symptoms (DRESS) is a rare and severe multiorgan drug reaction whose pathophysiological mechanisms underlying remain unclear, but may involve the role of several immune cells like eosinophils. iIndeed,the number of eosinophils is incre…
Phase 2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
A blood test for hidden colon cancer risk?
Diagnosis Not yet recruitingThe goal of this prospective interventional biomarker development and validation study is to determine whether circulating tumour DNA (ctDNA) can be detected in patients with large pre-neoplastic colorectal lesions undergoing endoscopic resection and whether ctDNA can be used to …
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
Can a camera catch autism signs in preemie toddlers?
Diagnosis Not yet recruitingThis is a single center, intervention study of integrating the eye-tracking (ET) biomarker battery into the existing autism evaluation process at the Riley Early Years Program (EYP). Eligible participants referred for autism testing through EYP will undergo a traditional comprehe…
Sponsor: Indiana University • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Can a 10-Week coaching program ease the toll on heart failure caregivers?
Symptom relief Not yet recruitingThis study will test the mechanisms of a multi-component, nurse-led, primary palliative care intervention, HEart failure Resilience Intervention for Caregivers (HEROIC) to improve caregiver mental well-being, patient health-related quality of life and unplanned acute care in the …
Phase 2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can an experimental drug stop polyps from coming back in a rare inherited condition?
Disease control Not yet recruitingThis is a Phase 1b, open- label, dose-optimization study evaluating ST316 in adult participants with familial adenomatous polyposis (FAP) who have undergone colectomy and have recurrent polyps. This study uses a three-cohorts, sequential adaptive design to assess the safety, tole…
Phase 1 • Sponsor: Sapience Therapeutics • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can an app help families tackle childhood obesity?
Disease control Not yet recruitingThe primary goal of this SBIR Direct to Phase II is to expand upon the existing training platform to create an "all-in-one" digital product, FBT 2.0, that offers an integrated suite of intervention components, including (a) dynamic, personalized, self-paced program for children a…
Sponsor: 3-C Institute for Social Development • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug cocktails aim to outsmart Hard-to-Treat T-Cell lymphomas
Disease control Not yet recruitingThis phase I trial tests the safety, side effects and best dose of azacitidine in combination with belinostat and how well the combination works in treating patients with follicular helper T cell lymphoma (TFH) that has come back after a period of improvement (relapsed) or that h…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Promising combo targets tough leukemia
Disease control Not yet recruitingB-cell acute lymphoblastic leukemia (B-ALL) is an aggressive blood cancer; about 30% of B-ALL cases in adults have a mutation called BCR-ABL that drives the disease. Blinatumomab is an antibody drug that targets B-ALL cells and helps the immune system to kill them. It is usually…
Phase 2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a shingles vaccine help fight deadly brain cancer?
Disease control Not yet recruitingIn modern practice a trimodality treatment has emerged as standard of care for histologically confirmed glioblastoma. We hypothesize that the additional vaccination against herpes zoster, after surgical resection followed by irradiation therapy and chemotherapy of patients with …
Phase 4 • Sponsor: University Hospital, Essen • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Goat milk ladder may offer a new route to milk tolerance in allergic children
Disease control Not yet recruitingChildren with immunoglobulin E (IgE)-mediated cow's milk allergy (CMA) who react to small amounts of baked cow's milk may require prolonged elimination. Preliminary observations suggest that some may tolerate products prepared with a low-αs1-casein goat milk formula. This study w…
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a kidney drug stop acute injury from becoming chronic?
Disease control Not yet recruitingThis study is testing whether finerenone, when compared to placebo, is a tolerable and safe intervention when administered in patients with acute kidney injury (AKI). This study will explore whether finerenone can mitigate the risk of transitioning to chronic kidney disease follo…
Sponsor: Jean-Maxime Côté • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can custom foot orthoses outperform standard ones for painful flatfoot?
Symptom relief Not yet recruitingBackground Progressive collapsing foot deformity (PCFD) is a painful musculoskeletal disorder leading to a progressively developing flat foot, which affects mobility and function and negatively impairs quality of life. Foot orthoses (FOs) are often prescribed to attenuate pain an…
Sponsor: Université du Québec à Trois-Rivières • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Can mindfulness calm the breath and mind in lung cancer?
Symptom relief Not yet recruitingThe study aims to examine the effectiveness of M-RDSI (Mindfulness-Respiratory Distress Symptom Intervention) in Hong Kong (HK) Chinese patients with lung cancer (LC). Investigators will conduct a three-arm mixed-methods randomized controlled trial (RCT) involving 189 patients wi…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Mailed test strips aim to slash opioid overdose deaths
Prevention Not yet recruitingThis Type 1 hybrid effectiveness-implementation randomized controlled trial, A Remote Intervention to Prevent Overdose among People who Use Stimulants and/or Opioids, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdo…
Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
3D-Printed brain surgery guide may stop dangerous blood clots from returning
Disease control Not yet recruitingChronic subdural hematoma is a collection of blood and fluid on the surface of the brain that is common in older adults. Burr-hole drainage is a standard surgical treatment, but the hematoma may come back in some patients and require another procedure.This study will test whether…
Sponsor: The Second Hospital of Anhui Medical University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Brain training before facing fears may boost anxiety therapy
Disease control Not yet recruitingAnxiety disorders remain are among the most prevalent psychiatric conditions and are associated with negative outcomes spanning poor health to increased suicide risk. While exposure therapy is recognized as a gold standard empirically supported treatment, many individuals fail to…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new patch seal the Brain's protective lining and stop leaks?
Disease control Not yet recruitingThe purpose of the NEOFIX study is to evaluate the safety and efficacy of ArtiFix® dural sealant graft in comparison to usual treatment for Dural repair (membrane that covers the brain and spinal cord) following cranial and spine surgeries. The investigated device will be implant…
Sponsor: Nurami Medical Ltd • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC